Seeking Alpha

Par Pharmaceutical (PRX): Q2 EPS of $1.62 beats by $0.52. Revenue of $294.3M (+36.9% Y/Y) beats...

Par Pharmaceutical (PRX): Q2 EPS of $1.62 beats by $0.52. Revenue of $294.3M (+36.9% Y/Y) beats by $3.M. (PR)
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector